Although investor concerns about the MedTech Sector have been based on expected declines in obesity rates with the surging adoption of GLP-1s, IQVIA MedTechs analysis of the data tells a different story, overall, that - to date - obesity diagnoses remain stable during the rise of GLP-1 uptake as depicted below: As a result, the resilience of obesity diagnosis occurring despite the rising uptake of GLP-1s should serve as a positive general signal for MedTech industry players to counter investor concerns about the potential of reduced demand, or that the demand may be net-neutral, rather than a sudden decline
Obesity leads to chronic inflammation, he said, and that inflammation has very clear effects on your arteries and your cardiovascular system. Reducing that inflammation with GLP-1s, it turns out, reduces cardiovascular risk
Track your weekly doses, side effects, and weight to optimize your protocol in real-time
Semaglutide and other GLP-1 medications work by mimicking a natural hormone that regulates blood sugar and appetite, but this same action slows how fast food moves through your digestive system
1 in 4 St
While some unwanted side effects have come from the method, there have also been some that have been welcomed by users
-1775582746855.png&w=3840&q=75)
